eAbbvie
Pharmaceutical Product Catalog

Effective January 1, 2019, VIEKIRA XR and TECHNIVIE will no longer be available in the U.S.A. Until January 1, 2019, supply of these medications will be available for all patients who begin therapy prior to July 1, 2018, to ensure that they are able to obtain product necessary to complete their course of prescribed therapy. Accordingly, AbbVie advises that physicians should cease writing any new prescriptions for VIEKIRA XR and TECHNIVIE effective July 1, 2018.

nav nav
HUMIRA CROHN'S 80MG/0.8ML, 3 PENS
NDC number: 00074012403
Product Family: HUMIRA
Dosage Form: EA
Strength: 80 mg/0.8 mL
Imprint:
Approval Date: 04/21/2017
Controlled Substance: RX
Therapeutic Class:
TUMOR NECROSIS FACTOR (TNF) BLOCKER
   
Price
List Price: $16,339.28
List Effective Date: 01/01/2019
WAC Price: $15,522.32
WAC Effective Date: 01/01/2019
Product Dimensions
Each Length (in): 6.13
Each Width (in): 7.97
Each Height (in): 1.75
Packaging Details
Packaging Information
Unit Of Measure: EACH
Inner Pack:
Quantity / Salable Unit: 3X80 mg/0.8 mL
Case Size: 1
Total Cases / Pallet: 342
Total Pallet Weight (lbs): 440.82
Number of Tiers:
Cases / Tier:
Case Details
Case Weight (lbs): 0.79
Case Volume (cu ft): 95.74
Length (in) Width (in) Height (in)
Outer Case 6.56 8.06 1.81
Inner Case
Announcements
Additional Information
Product and pricing detail may change. Please return to www.e-abbvie.com for the current product and pricing information.
Copyright © Abbvie Version 2.5